The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
Bernanke Just Squashed the Gold Rally, Now What?
by Robert Williams, Publisher
Tuesday, December 8, 2009
Gold prices are in retreat – their steepest two-day decline since March – on the announcement by Fed Chairman Ben Bernanke that inflation “appears likely to remain subdued for some time.”
He also reminded us that the weak labor market (can you say jobless recovery?) and tight credit would provide “formidable headwinds” to the economy.
Those of you who read Investment U’s November 24 issue – We Apologize For Interrupting the Gold Rally, But… – knew this was coming. And I hope you took action…
And now, of course – on the heels of gold’s big thud – Wall Street’s big boys are weighing in, offering their outlooks.
Yesterday, JPMorgan Chase (NYSE: JPM) said, “Fundamentally, the gold price appears over-valued.”
And Credit Suisse (NYSE: CS) chimed in, asserting “Gold may decline to $900 to $1,000 an ounce by the end of the first quarter next year.”
Thanks again, fellas. But I’ll stick to what options expert, Karim Rahemtulla, is saying. He’s the one that called the decline two weeks ago based on the movement he was seeing in the options market.
So if you missed that article, here’s your chance to make amends and learn how to play gold’s next move…
Ahead of the tape,
Robert Williams
- What’s the “Fair Price” of Gold?
- Why the Gold Rally Has Some Feeling Cheated
- We Apologize for Interrupting the Gold Rally, But…
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
In addition to once being a full-time trader of equities and equity derivatives, Robert Williams has served as the lead financial analyst for a Forbes top-50 private corporation and an analyst for the endowment of a major academic institution. He's also been profiled in such books as Trade with Passion and Purpose and Alexander Green's The Secret of Shelter Island. 
Investment U RSS Feed